1. Home
  2. IMNM vs OSPN Comparison

IMNM vs OSPN Comparison

Compare IMNM & OSPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNM
  • OSPN
  • Stock Information
  • Founded
  • IMNM 2006
  • OSPN 1991
  • Country
  • IMNM United States
  • OSPN United States
  • Employees
  • IMNM N/A
  • OSPN N/A
  • Industry
  • IMNM Medicinal Chemicals and Botanical Products
  • OSPN EDP Services
  • Sector
  • IMNM Health Care
  • OSPN Technology
  • Exchange
  • IMNM Nasdaq
  • OSPN Nasdaq
  • Market Cap
  • IMNM 747.7M
  • OSPN 688.4M
  • IPO Year
  • IMNM 2020
  • OSPN 1998
  • Fundamental
  • Price
  • IMNM $12.01
  • OSPN $18.82
  • Analyst Decision
  • IMNM Strong Buy
  • OSPN Strong Buy
  • Analyst Count
  • IMNM 5
  • OSPN 5
  • Target Price
  • IMNM $28.60
  • OSPN $16.50
  • AVG Volume (30 Days)
  • IMNM 803.1K
  • OSPN 401.9K
  • Earning Date
  • IMNM 11-13-2024
  • OSPN 10-30-2024
  • Dividend Yield
  • IMNM N/A
  • OSPN N/A
  • EPS Growth
  • IMNM N/A
  • OSPN N/A
  • EPS
  • IMNM N/A
  • OSPN 0.75
  • Revenue
  • IMNM $10,129,000.00
  • OSPN $244,936,000.00
  • Revenue This Year
  • IMNM N/A
  • OSPN $4.28
  • Revenue Next Year
  • IMNM N/A
  • OSPN $3.43
  • P/E Ratio
  • IMNM N/A
  • OSPN $25.80
  • Revenue Growth
  • IMNM N/A
  • OSPN 7.05
  • 52 Week Low
  • IMNM $7.76
  • OSPN $9.22
  • 52 Week High
  • IMNM $30.96
  • OSPN $19.58
  • Technical
  • Relative Strength Index (RSI)
  • IMNM 43.70
  • OSPN 63.53
  • Support Level
  • IMNM $12.99
  • OSPN $18.03
  • Resistance Level
  • IMNM $15.13
  • OSPN $19.58
  • Average True Range (ATR)
  • IMNM 0.93
  • OSPN 0.60
  • MACD
  • IMNM -0.16
  • OSPN 0.00
  • Stochastic Oscillator
  • IMNM 3.79
  • OSPN 90.18

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.

About OSPN OneSpan Inc.

OneSpan Inc is a provider of information technology security solutions for banking and financial services and application security markets. Its solutions secure and manage access to digital assets and protect online transactions, via mobile devices and in-person. Authentication and anti-fraud solutions are the organization's primary product offerings and include multifactor authentication and virtual private network access capabilities. The company derives revenues from hardware and license fees, maintenance and support fees, and subscription fees. A large majority of the firm's revenue is generated in Europe, the Middle East, and Africa, and the rest in the United States and Asia-Pacific region.

Share on Social Networks: